Status: Not yet recruiting
Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis
The purpose of this study is to investigate the safety and tolerability of intrathecal riluzole in adults with amyotrophic lateral sclerosis.
Participants needed: 10
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Brain Trust BioUpdated: Jul 30, 2025Locations: 2
Eligibility criteria
Men and women aged 18 years or older. [+9]
Participants with bulbar-onset ALS [+18]